Lower Cancer Survival Rates in Rural Areas Highlight Disparities in Care Access

A new study finds cancer survival rates are lower in rural areas of the U.S., highlighting disparities in access to quality care and treatment among marginalized populations.
A recent comprehensive study conducted by researchers at the American Cancer Society reveals that cancer survival outcomes in the United States are significantly lower in non-metropolitan regions compared to urban areas. The research, published in the journal Cancer, examined data spanning from 2015 to 2021, focusing on five-year survival rates for various cancer stages and types, including lung, breast, prostate, and colorectal cancers.
The analysis showed that individuals residing in rural or less urbanized counties experience decreased survival rates across all cancer stages—localized, regional, and distant—compared to those in metropolitan areas. Specifically, survival rates for localized, regional, and distant-stage cancers were reduced by 2%, 5%, and 3–7%, respectively, in rural regions. Furthermore, Black patients tend to have lower survival rates than white patients, with disparities especially prominent in breast and colorectal cancers.
A critical factor contributing to these disparities appears to be the lower receipt of essential cancer treatments such as surgery, chemotherapy, and radiotherapy among rural populations. The study highlights that Black patients are less likely to receive timely and appropriate care, including surgery at local and regional stages, which further worsens survival outcomes.
"Lower survival rates for the same cancer stages in non-metropolitan areas largely reflect gaps in access to quality cancer care, which stems from social determinants of health like insurance coverage and systemic inequalities," explained Dr. Farhad Islami, senior scientific director of cancer disparity research at ACS. "Addressing these inequities requires increased access to high-quality, affordable cancer care, especially for marginalized populations."
The researchers used data from the Surveillance, Epidemiology, and End Results (SEER) program, analyzing cancer diagnoses by stage and treatment patterns. The findings underscore the urgent need for policies and interventions aimed at closing the gap in cancer care between urban and rural populations. Advocates emphasize that where someone lives should not determine their health outcomes, and strengthening healthcare infrastructure and outreach in rural areas is essential.
Healthcare leaders and organizations like the American Cancer Society are urging Congress to boost funding for preventive and early detection programs and extend health care tax credits to make cancer care more accessible. Improving care accessibility and reducing social barriers are vital steps toward ensuring equitable cancer survival for all Americans.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
FDA Approves First Blood Test for Alzheimer’s Disease: Key Insights
The FDA has approved the first blood test for Alzheimer’s disease, offering a less invasive, accessible, and early diagnostic option that could revolutionize patient care and research.
CDC No Longer Recommends COVID-19 Vaccines for All, Leaves Vaccination Choices to Individuals
The CDC has stopped recommending COVID-19 vaccines for all populations, advising individuals to consult healthcare providers for vaccination decisions amid policy shifts and ongoing debates about vaccine safety.
Impact of Dobbs v Jackson Decision on Abortion Provider Relocation in Banning States
A recent study reveals that 42% of abortion providers in states with bans have relocated post-Dobbs, impacting healthcare access and maternal outcomes. Learn more about this significant shift in reproductive healthcare.
Advancing Toward a Tuberculosis-Free Southeast Asia: ASEAN's Vaccination Strategies and Digital Innovation
ASEAN is progressing towards a tuberculosis-free future through vaccine diplomacy, innovative digital health tools, and regional collaboration, aiming to eliminate TB by 2035.



